Source 1review2019Cell Biology and Toxicology
Toolkit/switchable Cas9 variants
switchable Cas9 variants
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Switchable Cas9 variants are an engineered CRISPR-Cas9 tool class discussed for in vivo gene editing in therapeutic applications. The available evidence establishes their relevance to therapeutic editing but does not specify particular switch architectures or functional designs.
Usefulness & Problems
Why this is useful
This tool class is presented in the context of therapeutic in vivo gene editing, indicating utility for controlled application of CRISPR-Cas9 in living systems. The supplied evidence does not detail which therapeutic constraints or use cases were experimentally addressed.
Problem solved
The cited review frames switchable Cas9 variants as relevant to in vivo gene editing for therapeutic use. Based on the provided evidence, the specific engineering problem solved by these variants is not described beyond enabling therapeutic editing contexts.
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete method used to build, optimize, or evolve an engineered system.
Mechanisms
No mechanism tags yet.
Techniques
No technique tags yet.
Target processes
editingImplementation Constraints
The available evidence only places switchable Cas9 variants within therapeutic in vivo gene editing. No practical details are provided regarding construct design, guide RNA format, expression system, delivery vehicle, cofactors, or activation conditions.
The evidence does not identify any specific switch mechanism, Cas9 variant, delivery strategy, target tissue, or validation dataset. As a result, functional capabilities, safety properties, and therapeutic performance cannot be assessed from the supplied sources.
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
This review addresses the application of switchable Cas9 variants to in vivo gene editing for therapeutic use.
This review addresses the application of switchable Cas9 variants to in vivo gene editing for therapeutic use.
This review addresses the application of switchable Cas9 variants to in vivo gene editing for therapeutic use.
This review addresses the application of switchable Cas9 variants to in vivo gene editing for therapeutic use.
This review addresses the application of switchable Cas9 variants to in vivo gene editing for therapeutic use.
This review addresses the application of switchable Cas9 variants to in vivo gene editing for therapeutic use.
This review addresses the application of switchable Cas9 variants to in vivo gene editing for therapeutic use.
Approval Evidence
1 source1 linked approval claimfirst-pass slug switchable-cas9-variants
Applying switchable Cas9 variants to in vivo gene editing for therapeutic applications
Source:
review scopesupports
This review addresses the application of switchable Cas9 variants to in vivo gene editing for therapeutic use.
Source:
Comparisons
Source-backed strengths
A strength supported by the evidence is that switchable Cas9 variants are considered sufficiently mature or relevant to be reviewed for therapeutic in vivo gene editing. No specific performance metrics, editing outcomes, or comparative advantages are provided in the supplied material.
Ranked Citations
- 1.